Slide Show: The Quest for an Effective Ebola Vaccine

Slideshow

Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (manufactured by Merck, Sharp & Dohme) is highly effective against Ebola. The independent body of international experts - the Data and Safety Monitoring Board – that conducted the review, advised that the trial should continue. Preliminary results from analyses of these interim data are published today in The Lancet. This slide show provides details about the trial and presents a pictoral gallery. 

Recent Videos
Meet Shannon Simmons, DHSc, MPH, CIC.
Meet Matthew Pullen, MD.
Clostridioides difficile (Adobe Stock 260659307 by gaetan)
David Levine, PhD, DPT, MPH, FAPTA
Weekly Rounds with Infection Control Today
Henry Spratt, Infection Control Today's Editorial Advisory Board member
DEBORAH BIRX, MD, is a retired Army Colonel and Global Ambassador to 3 US presidents, Birx has over 40 years of experience fighting global pandemics. Her research and work have been credited with saving over 22 million lives in Africa through the PEPFAR program, and she has authored over 200 academic publications.
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Association for Professionals in Infection Control and Epidemiology (Image credit: APIC)
Related Content
Sean Brown, CIC, CPHQ, with author (Photo Courtesy of Carole W. Kamangu, MPH, RN, CIC)

Top 3 Secrets to Effective Infection Prevention and Control Through Strategic MDRO Surveillance

Carole W. Kamangu, MPH, RN, CIC
September 13th 2024
Article

Sean Brown’s 2024 Disease Prevention Summit presentation emphasized leveraging technology, prioritizing high-risk patients, and environmental surveillance to enhance infection prevention and control strategies.

3D illustration: Candida auris (Adobe Stock 635576411 By Niamh)

Fungus Among Us: The Rising Threat of Candida auris in Health Care Settings and How to Mitigate It

Carole W. Kamangu, MPH, RN, CIC
September 12th 2024
Article

A presentation at the Disease Prevention and Control Summit in Philadelphia, Pennsylvania, spoke about the rising threat of Candida auris.

APIC: Association for Professionals in Infection Control and Epidemiology (Logo credit to APIC)

Recertification Options for a-IPC, APIC's Emerging Infectious Diseases Task Force and Mpox Playbook

Infection Control Today® Editorial Staff
September 12th 2024
Article

Learn about the new Recertification option for the a-IPC certification, and the APIC's Emerging Infectious Diseases Task Force, and the Mpox Playbook.

Pathogen Pulse With Isis Lamphier, MPH, CIC

Top 3 Infection Prevention Events to Watch Now: Eastern Equine Encephalitis, Listeria, and Mpox

Isis Lamphier, MPH, CIC
September 11th 2024
Article

This week's Pathogen Pulse highlights: Eastern Equine Encephalitis Virus (EEEV), Boar's Head products recall due to listeria contamination, and mpox cases on the rise in Africa.

Trending Topics From Infection Control Today

Trending Topics: COVID-19 and Mpox Vaccine Updates and Doubling Syphilis Detection

Infection Control Today® Editorial Staff
September 10th 2024
Article

Read today's updates on COVID-19 and Mpox vaccines and a study released today on doubling syphilis detection in the emergency department.

Long-term Care Chronicles With Robbie Hilliard, MSN, RN, CIC

An Ounce of Prevention: Managing Influenza and COVID-19 in Long-Term Care

Robbie Hilliard, MSN, RN, CIC
September 10th 2024
Article

As influenza and COVID-19 circulate in long-term care facilities, prompt testing, isolation precautions, and antiviral treatments are crucial for preventing outbreaks and protecting vulnerable residents.